Navigation Links
Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
Date:5/29/2008

SAN MARINO, Calif., May 29 /PRNewswire/ -- Epeius Biotechnologies (http://www.epeiusbiotech.com) announced today the results of an on-going Phase I/II study of Rexin-G for metastatic bone and soft tissue sarcoma (J Clin Oncol 26: 14509, 2008). Rexin-G is the first and so far only targeted gene therapy vector that has been tested in the clinic (Nature Reviews/Genetics 2007). In this open label study, cohorts of 6 to 7 patients with all types of sarcoma, including osteosarcoma, Ewing's sarcoma, leiomyosarcoma, malignant fibrous histiocytoma, chondrosarcoma, fibrosarcoma, liposarcoma, angiosarcoma, spindle cell sarcoma, and malignant mixed Mullerian tumor of ovary, were treated with 1 x 10e11 cfu Rexin-G, administered i.v. over 5 minutes, 2 times a week for 4 weeks (Cumulative Dose = 8 x 10e11 cfu) followed by a 2-week rest period. Patients with Grade 1 or less toxicity were given progressive intra-patient dose-escalations consisting of additional treatment cycles of 1 to 2 x 10e11 cfu three times a week for 4 weeks (Cumulative Dose per cycle: 1.2-2.4 x 10e12 cfu).

These higher dosing regimens were associated with prolonged disease stabilization and a median overall survival of greater than 6 months, which was three times longer than that observed in the low-dose group. Further, histologic examination of resected tumors showed 50-90% necrosis. No dose-limiting toxicity was observed, even at the higher doses of Rexin-G, thus confirming that repeated infusions of Rexin-G are safe and well-tolerated. Taken together with previous clinical studies conducted in the Philippines and Japan, these studies confirm the exemplary safety and dose-dependent efficacy of Rexin-G in a broad spectrum of chemotherapy-resistant cancers.

For more information about Rexin-G, on-going clinical trials in the USA and abroad, and/or Epeius pathotropic (disease-seeking) gene delivery systems, please contact Dr. Erlinda M
'/>"/>

SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
2. Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial
3. Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
4. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
5. Genmab Announces Updates on Phase III Cancer Studies
6. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
7. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
8. BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. First Patient Enrolled in Global Phase III Study of Bevacizumab and Trastuzumab in Early Breast Cancer
11. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and MECHELEN, Belgium , ... and AbbVie (NYSE: ABBV ) announced today ... include Crohn,s disease.  Galapagos will fund and complete a ... to facilitate rapid progression into Phase 3.  Upon successful ... will pay Galapagos $50 million.  The terms of the ...
(Date:5/16/2013)... RALEIGH, N.C. , May 16, 2013  Today, ... North Carolina House of Representatives recently ... coverage for chemotherapy from charging patients higher out-of-pocket fees ... IV formularies, many of which have more severe side-effects. ... out-of-pocket limit of $300, which will continue to be ...
(Date:5/16/2013)... 2013  Amgen (NASDAQ: AMGN ) will participate ... 21, 2013, at the Sheraton New York Times Square in ... a.m. Eastern Daylight Time. Joseph P. Miletich ... at Amgen, will present at the conference. Live audio of ... Amgen,s website, www.amgen.com , under Investors. A replay of ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... CryoLife, Inc. (NYSE: CRY ), ... announced today its results for the fourth quarter and the ... 2 percent to a fourth quarter record of $29.2 million ...   "We are pleased to experience yet another ...
... Feb. 17, 2011 Perrigo (Nasdaq: PRGO ; ... agreement with AgaMatrix, Inc. to sell and distribute blood glucose ... As part of the agreement, Perrigo will sell and distribute ... certain future new products. AgaMatrix is a privately held company ...
Cached Medicine Technology:CryoLife Posts Record Annual Revenues of $116.6 Million 2CryoLife Posts Record Annual Revenues of $116.6 Million 3CryoLife Posts Record Annual Revenues of $116.6 Million 4CryoLife Posts Record Annual Revenues of $116.6 Million 5CryoLife Posts Record Annual Revenues of $116.6 Million 6CryoLife Posts Record Annual Revenues of $116.6 Million 7CryoLife Posts Record Annual Revenues of $116.6 Million 8CryoLife Posts Record Annual Revenues of $116.6 Million 9CryoLife Posts Record Annual Revenues of $116.6 Million 10CryoLife Posts Record Annual Revenues of $116.6 Million 11CryoLife Posts Record Annual Revenues of $116.6 Million 12CryoLife Posts Record Annual Revenues of $116.6 Million 13CryoLife Posts Record Annual Revenues of $116.6 Million 14CryoLife Posts Record Annual Revenues of $116.6 Million 15Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products 2Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products 3
(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases de Yoga ... by the Sivananda Yoga Vedanta Center. The center ... Norte). Classes are 90 minutes and are offered all ... a calm environment, allowing visitors to enjoy the benefits ... among others. , The Yoga classes follow the following ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 The legal ... website YazSideEffects.com in a concerted effort to connect women ... combination birth control drugs Yaz, Yasmin & Ocella with ... wealth of information on the notorious birth control drugs ... Bayer Pharmaceuticals. , Yaz, Yasmin & Ocella were ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Daily Gossip issued ... a new review on their page. John Colston, Daily Gossip’s ... to Shaun Hadsall’s revolutionizing 14-Day Rapid Fat Loss Plan ... sustain that carbs are healthy at a time when nutritionists ... from highly caloric products. , The diet is based ...
(Date:5/18/2013)... May 18, 2013 Also known as ... increasingly popular weight loss surgery that guarantees patients long-term ... Center wishes to give readers a brief tutorial ... attended medical school at New York City’s Mount Sinai ... Methodist he undertook a fellowship in Minimally Invasive Bariatric ...
(Date:5/18/2013)... May 18 (HealthDay News) -- Children who swallow high-powered ... remove the objects, according to a new study. ... in New Orleans, found that more than 79 percent ... either surgery or an endoscopic procedure, in which a ... tract. Only 21 percent of these cases can be ...
Breaking Medicine News(10 mins):Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2Health News:Yazsideeffects.com Connects Yaz Side Effects Sufferers With Yaz Side Effects Lawyers 2Health News:Everything You Need to Know About Lap Band Surgery 2Health News:Everything You Need to Know About Lap Band Surgery 3Health News:Swallowing Magnets Can Be Fatal for Children 2
... , , WOONSOCKET, R.I., ... not take their medications, but being busy or simply forgetting top the ... ten consumers (28%) sometimes forget to refill their prescriptions on time, and ... to a daily medication schedule. In addition, more than half (52%) ...
... , , , ... 13 As Americans are becoming increasingly aware of probiotics, ... and Prebiotics (ISAPP) provide increased clarity about the definition of ... percent) of Americans said they are aware of the term ...
... R.I., Aug. 13 CVS Caremark (NYSE: CVS ... examined consumer attitudes and behaviors around health care and prescription usage. ... coverage along with cost savings realized by improving health care delivery. , ... E75914LOGO ) , , Of all consumers ...
... , , , ... American Veterinary Medical Association (AVMA) is unveiling a new online pre ... multiple improvements to the tools and resources available to journalists. , , ... covering the complex and often controversial issues in veterinary medicine as easy as ...
... , ALLEGAN, Mich., Aug. 13 Perrigo ... its Board of Directors declared a quarterly dividend of $0.055 ... record on August 28, 2009. , , ... that develops, manufactures and distributes over-the-counter (OTC) and generic prescription ...
... Israel, Aug. 13 Shamir Optical Industry Ltd. (Nasdaq: ... and technology to the ophthalmic lens market, today announced unaudited financial ... , For the quarter ended June 30, 2009, revenues ... same period in 2008. The decrease in revenues was mainly due ...
Cached Medicine News:Health News:CVS/pharmacy Helping Consumers with Challenge of Filling Prescriptions on Time 2Health News:CVS/pharmacy Helping Consumers with Challenge of Filling Prescriptions on Time 3Health News:New Guidelines Provide Clarity About Probiotics 2Health News:CVS Caremark Announces Results of 2009 Health IQ Study 2Health News:CVS Caremark Announces Results of 2009 Health IQ Study 3Health News:AVMA Unveils Improved Online Press Room to Help Journalists 2Health News:AVMA Unveils Improved Online Press Room to Help Journalists 3Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 2Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 3Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 4Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 5Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 6Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 7Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 8Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 9Health News:Shamir Optical Industry Ltd. Reports Second Quarter 2009 Results 10
... readers offering 96-channel parallel detection of fluorescence, ... 1,536-well microtiter plates. Compact workstations and ... the transport of microtiter plates with a ... The need for mechanical switching required by ...
... 1495-051 96PW washes all 96 ... and automatically. Separate wash and ... and excellent washing ability. Pre-programmed ... easily removable 96-channel head reduce ...
... SkanWasher 300 with ... system. Vacuum pressure and ... heights are adjustable. On-board ... configure 8 different programs. ...
... Automatic 96-well microplate washer ... Vacuum pressure, air pressure, and ... are adjustable. On-board software for ... programs. External vacuum pump required. ...
Medicine Products: